Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and globally Company prudently managing financial resources through reduced expenses and held approximately $20 Million in cash at the end of June 2020, after closing Q1 with $24 Million and Q4 2019 with $36 Million Received authorization forContinue reading “Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone”

Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

TORONTO, July 24– Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce call-in numbers and webcast link for the Annual General and Special Meeting of the shareholders of Blueberries Medical Corp. (the “AGM”).   The AGM will be held on Friday,Continue reading “Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)”

Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour

Attendees are invited to attend a real-time, interactive tour of Khiron’s recently completed Zerenia medical facility – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, Khiron CEO and Director will lead a live, on-camera virtual tourContinue reading “Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour”